((自动化翻译由路透提供，请见免责声明 ))
10月7日 - ** 制药商辉瑞 股价盘前上涨2.1%至29.2美元
** 激进投资者Starboard Value (link) 持有辉瑞约10亿美元的股份
** Starboard的目标是进行改革，以扭转辉瑞的业绩，因为该公司正努力应对其COVID疫苗销售额下降的问题。
** Starboard 还接触了辉瑞公司前首席执行官 Ian Read 和前首席财务官 Frank D'Amelio；两人都表示有兴趣帮助激进投资者。
** 辉瑞还因呼吸道合胞病毒(RSV) 疫苗的上市低于预期以及正在开发的肥胖药丸的临床数据令人失望而受到打击。
** 大多数券商对该股的评级为 "持有"；其PT中值为32.5美元--LSEG数据
** 截至收盘，PFE股价年累计下跌0.72%，而标普500指数 上涨20.57%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.